Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dale Schenk

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|September 25, 2007
Amyloid beta-protein precursor juxtamembrane domain regulates specificity of gamma-secretase-dependent cleavagesZhao Ren, Dale Schenk, Guriqbal S Basi, et al.
Journal of Alzheimer'S Disease : JAD|August 18, 2006
Mice as models: transgenic approaches and Alzheimer's diseaseDora Games, Manuel Buttini, Dione Kobayashi, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 16, 2005
Amyloid-beta neurotoxicity is mediated by FISH adapter protein and ADAM12 metalloprotease activityNikolay L Malinin, Sarah Wright, Peter Seubert, et al.
The Journal of Chemical Physics|July 26, 2013
Identification of small-molecule binding pockets in the soluble monomeric form of the Aβ42 peptideMaximillian Zhu, Alfonso De Simone, Dale Schenk, et al.
Experimental Neurology|August 16, 2012
Sustained levels of antibodies against Aβ in amyloid-rich regions of the CNS following intravenous dosing in human APP transgenic miceFrédérique Bard, Michael Fox, Stuart Friedrich, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 12, 2002
Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapyBrian J Bacskai, Stephen T Kajdasz, Megan E McLellan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 11, 2009
Abeta immunotherapy: intracerebral sequestration of Abeta by an anti-Abeta monoclonal antibody 266 with high affinity to soluble AbetaKaoru Yamada, Chiori Yabuki, Peter Seubert, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 3, 2006
Increased T cell recruitment to the CNS after amyloid beta 1-42 immunization in Alzheimer's mice overproducing transforming growth factor-beta 1Marion S Buckwalter, Bronwen S Coleman, Manuel Buttini, et al.
Neuron|June 20, 2014
β-Amyloid inhibits E-S potentiation through suppression of cannabinoid receptor 1-dependent synaptic disinhibitionAdrienne L Orr, Jesse E Hanson, Dong Li, et al.
The American Journal of Pathology|August 28, 2004
Morphological characterization of Thioflavin-S-positive amyloid plaques in transgenic Alzheimer mice and effect of passive Abeta immunotherapy on their clearanceThierry Bussière, Frédérique Bard, Robin Barbour, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|September 25, 2007
Amyloid beta-protein precursor juxtamembrane domain regulates specificity of gamma-secretase-dependent cleavagesZhao Ren, Dale Schenk, Guriqbal S Basi, et al.
Journal of Alzheimer'S Disease : JAD|August 18, 2006
Mice as models: transgenic approaches and Alzheimer's diseaseDora Games, Manuel Buttini, Dione Kobayashi, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 16, 2005
Amyloid-beta neurotoxicity is mediated by FISH adapter protein and ADAM12 metalloprotease activityNikolay L Malinin, Sarah Wright, Peter Seubert, et al.
The Journal of Chemical Physics|July 26, 2013
Identification of small-molecule binding pockets in the soluble monomeric form of the Aβ42 peptideMaximillian Zhu, Alfonso De Simone, Dale Schenk, et al.
Experimental Neurology|August 16, 2012
Sustained levels of antibodies against Aβ in amyloid-rich regions of the CNS following intravenous dosing in human APP transgenic miceFrédérique Bard, Michael Fox, Stuart Friedrich, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 12, 2002
Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapyBrian J Bacskai, Stephen T Kajdasz, Megan E McLellan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 11, 2009
Abeta immunotherapy: intracerebral sequestration of Abeta by an anti-Abeta monoclonal antibody 266 with high affinity to soluble AbetaKaoru Yamada, Chiori Yabuki, Peter Seubert, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 3, 2006
Increased T cell recruitment to the CNS after amyloid beta 1-42 immunization in Alzheimer's mice overproducing transforming growth factor-beta 1Marion S Buckwalter, Bronwen S Coleman, Manuel Buttini, et al.
Neuron|June 20, 2014
β-Amyloid inhibits E-S potentiation through suppression of cannabinoid receptor 1-dependent synaptic disinhibitionAdrienne L Orr, Jesse E Hanson, Dong Li, et al.
The American Journal of Pathology|August 28, 2004
Morphological characterization of Thioflavin-S-positive amyloid plaques in transgenic Alzheimer mice and effect of passive Abeta immunotherapy on their clearanceThierry Bussière, Frédérique Bard, Robin Barbour, et al.
Pageof 7